nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.144	0.268	CbGbCtD
Metronidazole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.1	0.187	CbGbCtD
Metronidazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0627	0.117	CbGbCtD
Metronidazole—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0605	0.113	CbGbCtD
Metronidazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0583	0.109	CbGbCtD
Metronidazole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0429	0.08	CbGbCtD
Metronidazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0268	0.0499	CbGbCtD
Metronidazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0245	0.0457	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0167	0.0312	CbGbCtD
Metronidazole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000186	0.000401	CcSEcCtD
Metronidazole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000186	0.000401	CcSEcCtD
Metronidazole—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.0004	CcSEcCtD
Metronidazole—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000185	0.000399	CcSEcCtD
Metronidazole—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000398	CcSEcCtD
Metronidazole—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000184	0.000397	CcSEcCtD
Metronidazole—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000397	CcSEcCtD
Metronidazole—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000396	CcSEcCtD
Metronidazole—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000392	CcSEcCtD
Metronidazole—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000182	0.000392	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000391	CcSEcCtD
Metronidazole—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000181	0.00039	CcSEcCtD
Metronidazole—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00039	CcSEcCtD
Metronidazole—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00018	0.000389	CcSEcCtD
Metronidazole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.000388	CcSEcCtD
Metronidazole—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000388	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000387	CcSEcCtD
Metronidazole—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000385	CcSEcCtD
Metronidazole—Pain—Cisplatin—peripheral nervous system neoplasm	0.000178	0.000384	CcSEcCtD
Metronidazole—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000379	CcSEcCtD
Metronidazole—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000379	CcSEcCtD
Metronidazole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000378	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000377	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000376	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000375	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000375	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000374	CcSEcCtD
Metronidazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000173	0.000374	CcSEcCtD
Metronidazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000372	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000371	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00037	CcSEcCtD
Metronidazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000171	0.00037	CcSEcCtD
Metronidazole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000171	0.000369	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000367	CcSEcCtD
Metronidazole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000169	0.000365	CcSEcCtD
Metronidazole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000169	0.000364	CcSEcCtD
Metronidazole—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000361	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000361	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000361	CcSEcCtD
Metronidazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000167	0.000361	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.00036	CcSEcCtD
Metronidazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00036	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000358	CcSEcCtD
Metronidazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.000358	CcSEcCtD
Metronidazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000166	0.000357	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000356	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000164	0.000355	CcSEcCtD
Metronidazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000164	0.000355	CcSEcCtD
Metronidazole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000164	0.000354	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000354	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000352	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000352	CcSEcCtD
Metronidazole—Pain—Etoposide—peripheral nervous system neoplasm	0.000163	0.000351	CcSEcCtD
Metronidazole—Constipation—Etoposide—peripheral nervous system neoplasm	0.000163	0.000351	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000351	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000351	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00035	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00035	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000348	CcSEcCtD
Metronidazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000348	CcSEcCtD
Metronidazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000161	0.000347	CcSEcCtD
Metronidazole—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000346	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000346	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000342	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000342	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000339	CcSEcCtD
Metronidazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000157	0.000339	CcSEcCtD
Metronidazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000156	0.000337	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000337	CcSEcCtD
Metronidazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000156	0.000336	CcSEcCtD
Metronidazole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000155	0.000335	CcSEcCtD
Metronidazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000335	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000334	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000334	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000334	CcSEcCtD
Metronidazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000332	CcSEcCtD
Metronidazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000332	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000331	CcSEcCtD
Metronidazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000153	0.00033	CcSEcCtD
Metronidazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.00033	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000328	CcSEcCtD
Metronidazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000151	0.000326	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000326	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000326	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000325	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.000325	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000151	0.000325	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000325	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000325	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000324	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000323	CcSEcCtD
Metronidazole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000149	0.000323	CcSEcCtD
Metronidazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00032	CcSEcCtD
Metronidazole—Rash—Vincristine—peripheral nervous system neoplasm	0.000148	0.00032	CcSEcCtD
Metronidazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000148	0.00032	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000319	CcSEcCtD
Metronidazole—Headache—Vincristine—peripheral nervous system neoplasm	0.000147	0.000318	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000316	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000314	CcSEcCtD
Metronidazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000313	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000312	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000312	CcSEcCtD
Metronidazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000307	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000307	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000303	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00014	0.000303	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000302	CcSEcCtD
Metronidazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.00014	0.000301	CcSEcCtD
Metronidazole—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000301	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000301	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000301	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.0003	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000299	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000298	CcSEcCtD
Metronidazole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000137	0.000295	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000295	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000294	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000293	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000292	CcSEcCtD
Metronidazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000135	0.000291	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000289	CcSEcCtD
Metronidazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000285	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000284	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000284	CcSEcCtD
Metronidazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000283	CcSEcCtD
Metronidazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000283	CcSEcCtD
Metronidazole—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000282	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00013	0.000281	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00028	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00028	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000278	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000278	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000278	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000276	CcSEcCtD
Metronidazole—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000273	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000272	CcSEcCtD
Metronidazole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000126	0.000272	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000271	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000271	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00027	CcSEcCtD
Metronidazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000266	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000266	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000263	CcSEcCtD
Metronidazole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000121	0.000261	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000261	CcSEcCtD
Metronidazole—Rash—Etoposide—peripheral nervous system neoplasm	0.00012	0.000259	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00012	0.000259	CcSEcCtD
Metronidazole—Headache—Etoposide—peripheral nervous system neoplasm	0.000119	0.000257	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000257	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000256	CcSEcCtD
Metronidazole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000255	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000254	CcSEcCtD
Metronidazole—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000253	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000253	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000253	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000251	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000249	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000248	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000246	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000245	CcSEcCtD
Metronidazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000113	0.000244	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000244	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00024	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00024	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000239	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000236	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000235	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000235	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000234	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000234	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000232	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000231	CcSEcCtD
Metronidazole—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00023	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00023	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00023	CcSEcCtD
Metronidazole—Infection—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000229	CcSEcCtD
Metronidazole—Shock—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000227	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000226	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000226	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000226	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000225	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000224	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000223	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000222	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000222	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000221	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00022	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000217	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000215	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.88e-05	0.000213	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.88e-05	0.000213	CcSEcCtD
Metronidazole—Infection—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000212	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.00021	CcSEcCtD
Metronidazole—Shock—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.00021	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000209	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000209	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000208	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000207	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000207	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.000206	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.49e-05	0.000205	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000203	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.000203	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.0002	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000199	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000199	CcSEcCtD
Metronidazole—Constipation—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000197	CcSEcCtD
Metronidazole—Pain—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000197	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9e-05	0.000194	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000193	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000191	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.00019	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.000189	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000188	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000188	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000185	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000184	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000184	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000183	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000182	CcSEcCtD
Metronidazole—Pain—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000182	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000182	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000182	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000176	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000174	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.00017	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.000169	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000168	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000168	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000165	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000163	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000158	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000157	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000153	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000152	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000151	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000146	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000146	CcSEcCtD
Metronidazole—Rash—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000145	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000145	CcSEcCtD
Metronidazole—Headache—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000144	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000141	CcSEcCtD
Metronidazole—Nausea—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000137	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000136	CcSEcCtD
Metronidazole—Rash—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000134	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000134	CcSEcCtD
Metronidazole—Headache—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000134	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000127	CcSEcCtD
